MetaCap

Bon Natural Life (BON) vs Biote (BTMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Biote is the larger company by market cap ($26.3 million vs $8.5 million), about 3.1 times the size. On valuation, Bon Natural Life trades at a lower forward P/E (1.8x vs 3.3x for Biote). Biote converts more of its revenue into profit, with a net margin of 14.1% versus -10.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BON-9.93%BTMD-26.60%
+13%-8%-28%
Oct 7, 20261 yearNov 20, 2026
BON-9.93%BTMD-29.16%
+1%-15%-31%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BON versus BTMD key metrics
MetricBONBTMD
Share price$1.04$0.8147
Market cap$8.53M$26.28M
1-day change-0.50%-3.56%
YTD return—-68.67%
1-year return—-68.90%
5-year return—-91.64%
Forward P/E1.803.33
EPS (TTM)$-2.79$-0.07
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$18.67M$192.22M
Revenue growth (YoY)-21.70%-2.52%
Net income (latest FY)$-1.99M$27.05M
Gross margin20.77%71.46%
Operating margin-8.69%18.50%
Net margin-10.68%14.07%
52-week high$1.94$2.90
52-week low$0.95$0.81
Distance from 52-week high-46.14%-71.91%
Analyst consensus—none
Avg. price target upside—+220.36%
Average volume10.82K146.21K
Shares outstanding6.13M27.04M
Employees96223
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Biote is about 3.1 times larger than Bon Natural Life by market value ($26.28M vs $8.53M).
  • Biote is more profitable, keeping 14.1 cents of every revenue dollar as net income versus -10.7 cents for Bon Natural Life.
  • Biote grew revenue faster in its latest fiscal year (-2.52% vs -21.70%).

About Bon Natural Life

BON stock →

Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements.

Health Care · Medicinal Chemicals and Botanical Products · 96 employees

About Biote

BTMD stock →

biote Corp. operates in practice-building business within the hormone optimization space.

Health Care · Medicinal Chemicals and Botanical Products · 223 employees

BON vs BTMD FAQ

Which is bigger, Bon Natural Life or Biote?

Biote (BTMD) is larger, with a market capitalization of $26.28M compared with $8.53M for Bon Natural Life (BON).

Are Bon Natural Life and Biote in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons